Design Therapeutics, Inc. (DSGN)

NASDAQ: DSGN · Real-Time Price · USD

15.64

+0.98 (6.68%)

At close: Jul 2, 2026, 4:00 PM EDT

15.96

+0.32 (2.02%)

After-hours: Jul 2, 2026, 7:17 PM EDT

Design Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	12.77	16.86	22.56	21.2	26.5	298.57
Short-Term Investments	210.05	202.99	222.91	260.6	303.89	85.5
Cash & Short-Term Investments	222.82	219.85	245.48	281.8	330.39	384.06
Cash Growth	-2.98%	-10.44%	-12.89%	-14.71%	-13.98%	964.15%
Other Current Assets	4.23	3.94	2.56	2.79	4.73	1.37
Total Current Assets	227.05	223.78	248.04	284.58	335.12	385.44
Net Property, Plant & Equipment	3.39	2.42	3.63	4.63	5.56	5.12
Other Long-Term Assets	-	-	0.43	0.43	0.46	-
Total Assets	230.44	226.2	252.09	289.64	341.14	390.56
Accounts Payable	2.28	2.31	2.19	1.94	3.03	1.62
Accrued Expenses	7.91	10.74	6.28	7.68	7.75	3.66
Total Current Liabilities	10.19	13.06	8.46	9.62	10.78	5.28
Long-Term Leases	2.2	0.65	1.53	2.33	3.05	3.14
Total Long-Term Liabilities	2.2	0.65	1.53	2.33	3.05	3.14
Total Liabilities	12.39	13.7	10	11.96	13.83	8.43
Common Stock	0.01	0.01	0.01	0	0.01	0.01
Additional Paid-in Capital	532.96	509.1	468.83	455.25	441.42	429.82
Accumulated Other Comprehensive Income	-0.27	0.4	0.48	0.06	-3.36	-0.24
Retained Earnings	-314.64	-297.01	-227.21	-177.63	-110.76	-47.46
Total Common Shareholders' Equity	218.05	212.5	242.1	277.69	327.31	382.13
Shareholders' Equity	218.05	212.5	242.1	277.69	327.31	382.13
Total Liabilities & Equity	230.44	226.2	252.09	289.64	341.14	390.56
Total Debt	2.2	0.65	1.53	2.33	3.05	3.14
Net Cash (Debt)	220.63	219.2	243.94	279.46	327.34	380.92
Net Cash Growth	0.65%	-10.14%	-12.71%	-14.63%	-14.07%	955.44%
Net Cash Per Share	3.77	3.82	4.31	4.99	5.88	8.29
Book Value	218.05	212.5	242.1	277.69	327.31	382.13
Book Value Per Share	3.73	3.71	4.28	4.96	5.88	8.32
Tangible Book Value	218.05	212.5	242.1	277.69	327.31	382.13
Tangible Book Value Per Share	3.73	3.71	4.28	4.96	5.88	8.32

SEC Filings: 10-K · 10-Q